CIAM
AEMD icon

Caitong International Asset Management’s Aethlon Medical AEMD Stock Holding History

Caitong International Asset Management’s Portfolio AEMD Stock Details AEMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2
Closed -$18 – 2966
2026
Q1 		$18 Buy
+2
New +$23 ﹤0.01% 2085

Other funds holding AEMD

HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
SC
Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SRL
Scientech Research LLC Jersey City, New Jersey $123M AUM 198.31% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Caitong International Asset Management's AEMD Position: Q2 2026 in Review

Caitong International Asset Management sold out of Aethlon Medical (AEMD) in Q2 2026, closing a stake of 2 shares — an estimated $18 sold.

Caitong International Asset Management first reported a position in AEMD in Q1 2026 and held it in 1 quarter. The position peaked at $18 in Q1 2026. 15 funds tracked by Wall St. Rank hold AEMD as of Q2 2026.

  • Caitong International Asset Management reported no remaining Aethlon Medical position as of Q2 2026 after selling out during the quarter.
  • Caitong International Asset Management sold 2 Aethlon Medical shares in Q2 2026, an estimated $18.
  • Caitong International Asset Management first reported a position in Aethlon Medical in Q1 2026 and held it in 1 quarter.
  • Caitong International Asset Management's Aethlon Medical position peaked at $18 in Q1 2026.
  • 15 funds tracked by Wall St. Rank held Aethlon Medical as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.